Another Discontinued Supplement with ATD Recalled

VISTA, Calif.Tribravus Enterprises LLC, dba iForce Nutrition, announced a voluntary national recall of all lots of Reversitol, which was marketed as a dietary supplement containing 6-etioallochol-1,4-diene-3,17-dione, or ATD, an aromatase inhibitor that stops the bodys production of estrogen. FDA informed the company it does not believe ATD is a dietary ingredient, making the product in violation of provisions of federal law.

FDA informed iForce of potential adverse events associated with the use of aromatase inhibitors, including infertility, adrenal insufficiencies, and kidney and liver dysfunction. The agency concluded products containing aromatase inhibitors are likely to cause adverse reactions in at-risk consumers, including those with liver, kidney, adrenal or prostate concerns.

iForce Nutrition discontinued production of Reversitol in December 2009; however, some retailers may still be selling remaining inventory. While the company has not received any adverse event reports associated with use of the product, it advised consumers to cease using the product and return the unused portion to the retail location where it was purchased or to the company directly. In its recall announcement, iForce Nutrition stated it disagreed with FDAs interpretation of the law, but agreed to the recall because the product had already been discontinued. This recall does not include Reversitol V2, which does not contain ATD.

Consumers who do have adverse reactions to the use of Reversitol can report the situation to FDA via the MedWatch Adverse Event Reporting program online.